CLINICAL_TRIALS ClinicalTrials.gov record update

Essai de Phase IV, Multicentrique, Ouvert, Visant à Tester la différence d'efficacité du Natalizumab, Versus le Fingolimod, 2 médicaments Ayant Une AMM Pour le Traitement de la sclérose en Plaques

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01981161
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:03.530414+00:00
Published At: 2020-08-25T00:00:00+00:00
Record Updated At: 2020-08-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Multiple Sclerosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-08-25"
protocolSection.identificationModule.nctId: "NCT01981161"
protocolSection.identificationModule.officialTitle: "Essai de Phase IV, Multicentrique, Ouvert, Visant \u00e0 Tester la diff\u00e9rence d\u0027efficacit\u00e9 du Natalizumab, Versus le Fingolimod, 2 m\u00e9dicaments Ayant Une AMM Pour le Traitement de la scl\u00e9rose en Plaques"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.